Barnaby Pickering
Reporter, Medtech Insight
Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.
Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.
Latest From Barnaby Pickering
Inivata Continues Trials Of Its Liquid Biopsy Platform
The partnership with the Princess Margaret Cancer Center will support two studies of liquid biopsy testing for lung cancer.
Exec Chat: Abionic Is Accelerating Diagnostics To Save Lives
Abionic CEO Nicolas Durand explains how Abionic is filling unmet needs in diagnostics and the Swiss company’s plans for expansion.
Exec Chat: MeMed Improves Diagnostics To Combat Antimicrobial resistance
Kfir Oved, co-founder and CTO of MeMed, talked to Medtech Insight about diagnostic testing that can differentiate bacterial and viral infections to fight antimicrobial resistance.
Point Of Care Diagnostics Market Projected To Continue Rapid Growth
A new report from Informa's Meddevicetracker highlights strong projected growth in the market, explaining the underlying reasons why.
Pear Therapeutics Obtains First Medicaid Coverage For PDTs
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.
Medtech Companies Face Challenges And Choices When Going Public
In a panel discussion at The Medtech Conference, hosted by AdvaMed, CEOs discussed the challenges, benefits and technicalities surrounding an IPO.